Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0000955
UniProt IDP09104
Primary gene name(s)ENO2
Synonym gene name(s)unknown
Protein nameGamma-enolase
Protein functionHas neurotrophic and neuroprotective properties on a broad spectrum of central nervous system, CNS neurons. Binds, in a calcium-dependent manner, to cultured neocortical neurons and promotes cell survival, By similarity. {ECO:0000250}.
Subcellular locationCytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Can translocate to the plasma membrane in either the homodimeric, alpha/alpha or heterodimeric, alpha/gamma form. {ECO:0000250}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P09104
Gene Ontology
(Biological Process)
Complete annatation
canonical glycolysis [GO:0061621];
gluconeogenesis [GO:0006094]
Gene Ontology
(Molecular Function)
Complete annatation
magnesium ion binding [GO:0000287];
phosphopyruvate hydratase activity [GO:0004634]
Gene Ontology
(Cellular Component)
Complete annatation
cytosol [GO:0005829];
extracellular exosome [GO:0070062];
extracellular space [GO:0005615];
myelin sheath [GO:0043209];
perikaryon [GO:0043204];
phosphopyruvate hydratase complex [GO:0000015];
photoreceptor inner segment [GO:0001917];
plasma membrane [GO:0005886]
Protein-protein interaction108340
Phylogenetic treeP09104
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
      unknown
Brass et al., Science, 2008
      unknown
Smith et al., J. Immunol, 2010
      unknown
Interferon-stimulated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model


DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-0.0274603834786410.933107877477720.9571118775925
AZA vs. DISU0.6187880485254180.01470300005620.295327171979136
AZA vs. IL7-0.007262966641546020.9698737635526250.999311006273513
AZA vs. SAHA0.3036190443052380.2137743565686720.581996326760701
DISU vs. CD30.6318501814921160.08207206399751290.159674018159333
DISU vs. IL7-0.6353874290417580.01190179635730490.130392136690677
DISU vs. SAHA-0.3120427117685990.2843526793797780.666530399683784
DMSO vs. AZA0.1218852174761390.4671881379254621
DMSO vs. CD30.1368122886121180.6685820234834620.754640607161036
DMSO vs. DISU-0.4988461612024650.04116234728180960.404906379593257
DMSO vs. IL7-0.1217426434427330.4984810238052610.885914818891506
DMSO vs. SAHA0.1767242307004380.4534454164425050.78360972403089
HIV vs. Mock in Activation0.5558367346591270.3730977847729630.999983755607037
HIV vs. Mock in Latency0.2137602041686830.5046958645536160.999834320637052
IL7 vs. CD30.02535546502279980.9370281446247630.960477743891809
SAHA vs. CD30.3075922550947690.3845479187653510.501092705213475
SAHA vs. IL70.3084356429320130.2058279395897020.439967436383319
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.2959 0.0298437
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.042 0.865 0.982 1.047 0.841
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
201313_at 1.54 No downregulated in CD8+ cells

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

Drugbank ID Drug Name Drug Status Pharmacological Action Drug Action
DB02726 2-Phosphoglycolic Acid experimental unknown unknown

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
1TE6 X-ray 1.8Å A/B=2-434.
2AKM X-ray 1.9Å A/B=2-434.
2AKZ X-ray 1.3Å A/B=2-434.
3UCC X-ray 1.5Å A/B=2-434.
3UCD X-ray 1.4Å A/B=2-434.
3UJE X-ray 1.5Å A/B=2-434.
3UJF X-ray 2.1Å A/B=2-434.
3UJR X-ray 1.4Å A/B=2-434.
3UJS X-ray 1.6Å A/B=2-434.
4ZA0 X-ray 2.3Å A/B=1-434.
4ZCW X-ray 1.9Å A/B=1-434.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00010 Glycolysis / Gluconeogenesis - Homo sapiens (human)
hsa01100 Metabolic pathways - Homo sapiens (human)
hsa01200 Carbon metabolism - Homo sapiens (human)
hsa01230 Biosynthesis of amino acids - Homo sapiens (human)
hsa03018 RNA degradation - Homo sapiens (human)
hsa04066 HIF-1 signaling pathway - Homo sapiens (human)
Menu